Thank you Monica and Linda, we are grateful for your insights Stanford Department of Medicine Stanford Div. of GI & Hepatology ACG

Nabil Fayad is taking us through the first round of GI jeopardy at the ACG annual meeting with Brooklyn Creighton Duke Iowa and National Capital Consortium fellows ⁦Mohammad Al-Haddad, FASGE,FACG, AGAF⁩ ⁦Indiana University Gastroenterology and Hepatology⁩

Congratulations to Dr Ronald Hsu who was awarded the community service award at the ACG 2023 annual meeting 👏👏👏⁦Ronald Hsu MD⁩ ⁦ACG⁩

Congratulations to Richie Manikat and Paul Shao who won awards for their outstanding fellow abstracts at the 2023 ACG meeting in liver and colorectal cancer categories. We are proud of both of you Stanford Div. of GI & Hepatology Stanford Medicine ACG

Join Ira M. Jacobson, MD, Dr. Tatyana Kushner, and Paul Kwo as they provide education and recommendations for early #HBV treatment and the evolving role of quantitative HBsAg monitoring in people living with chronic #hepatitisB. clinicaloptions.com/events/time-to… #LiverTwitter #AASLD

Hot off the press. The Stanford GI/Hepatology newsletter celebrating our commitments to clinical care, research, and teaching. Congratulations to renumathyd W Ray Kim and the entire division who are passionate about delivering the highest quality care Stanford Div. of GI & Hepatology

Congratulations to the award-winning Stanford Health Care team at the American Liver Foundation Liver Life Walk. Thanks for all your efforts to raise awareness and care for those with liver disease! Stanford Div. of GI & Hepatology Stanford Health Care Marc Melcher StanfordAbdTxp

So well deserved!

Continuous distribution is in the future for liver allocation.Dr. Allison Kwong is discussing how a new allocation system will be developed. Great job Allison!👋👋 ⁦AASLD⁩ ⁦Stanford Div. of GI & Hepatology⁩ ⁦Stanford Department of Medicine⁩

Join us to congratulate our division Chief Dr. Kim as he takes on the gavel as the President Elect of the AASLD! The current AASLD President passing the gavel to W Ray Kim! AASLD

Dr Ritchie Manikat reviews our experience with safety net candidates after liver transplant. Male sex and absence of diabetes predict renal recovery post liver transplant. Similar survival TO THOSE WHO UNDERGO SLK 👋👋👋👋! AASLD Stanford Div. of GI & Hepatology Stanford Department of Medicine

Our Stanford GI/Hepatology Fellow Mai Sedaki reports that in the obeticholic acid era, survival in those with decompensated cirrhosis due to PBC remained stable as assessed by MELD 3.0 with no excess mortality.👋👋👋#TLM Stanford Div. of GI & Hepatology Stanford Medicine AASLD

Dr Chalasani taking us through the evaluation to DILi DILI is a diagnosis of exclusion Need good history, exclusion of competing etiologies

Not all high creatinine is HRS AKI! With AKI in cirrhosis volume expand and withdraw diuretics. Address shock and infection ⁦Jasmohan Bajaj⁩ ⁦ACG⁩ at ACG BOG course in Las Vegas

Dr Mindie Nguyen discusses strategies to reduce HCC mortality at Stanford Medicine Grans Rounds.Earlier diagnosis and improved treatment options must be combined with prevention and treatment of primary liver diseases including ALD MASLD and viral hepatitis ⁦Stanford Div. of GI & Hepatology⁩

Can we refine our liver allocations for those with T2 tumors who require LT? Joshua Norman and Allison Kwong propose a model that improves wait list outcomes using MELD 3.0, tumor burden, and AFP. Congrats! Stanford Div. of GI & Hepatology Digestive Disease Week

Despite high efficacy rates of DAAs for HCV/cirrhosis patients, we need improved strategies to ensure screening for HCC post-SVR. We still fall short in early detection of HCC in this population.Congrats Richie !@Stanford_GI AASLD

Congratulations to Hepatologist, scientist, and entrepreneur extraordinaire Renu Dhanasekaran who today won the AGA innovator Shark Tank with her proposal to use AI to improve documentation and reimbursement for GI clinicians. Well done! Stanford Div. of GI & Hepatology AASLD W Ray Kim

Can GLP-RAs be beneficial in MetALD? Dr Amir Gougol Stanford Div. of GI & Hepatology notes that those with MetALD with at least 3 months of GLP exposure have reduced rates of hepatic decompensation and reduced mortality. Congratulations Amir. Stanford Div. of GI & Hepatology AASLD

Turning out the lights at DDW at the last session on inpatient Liver Consults Great discussions on hepatic complications of BMT, surgery in patients with liver disease, hbv reactivation and post Whipple complications ⁦AASLD⁩ ⁦American Gastroenterological Association (AGA)⁩ ⁦⁦